García-Cosío Carmena, MD, Farrero, M, Blasco Peiró, MT, Crespo, M, Delgado Jiménez, J, Díaz Molina, B, Fernández Rivera, C, Garrido Bravo, IP, López Jiménez, V, Melilli, E, Mirabet Pérez, S, Pérez Tamajón, ML, Rangel Sousa, D, Rodrigo, E, Cruzado, JM, Hernández Marrero, D. Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper. TRANSPLANTATION. 2025; 109(9)DOI:10.1097/TP.0000000000005302. PMID:39928546. IF:5.000(Q1/1D).

Audisio, A, Gallio, C, Velenik, V, Meillat, H, Ruiz-Garcia, E, Riesco, MC, Alecha, JS, Rasschaert, G, Carvalho, C, Randrian, V, Kirac, I, Hernando, J, Artac, M, O'Connor, JM, Waldhorn, I, Braam, PM, Shamseddine, A, Moretto, R, de la Pinta, C, De Felice, F, Dulskas, A, Lopez-Bravo, DP, Vanden Bulcke, A, Bock, F, Deleporte, A, van den Eynde, M, Geboes, KP, Loi, M, Messina, M, Houlze-Laroye, C, Puccini, A, Pastorino, A, Papamichael, D, Fiore, M, Sur, D, Eid, M, Antoun, C, Salati, M, Garajova, I, Jakubauskas, M, Tomasek, J, Pinto, CMS, Schwingel, J, Morano, F, Adams, RA, Dermine, A, Chau, A, Javed, MA, Ghidini, M, Fiorica, F, Montenegro, P, Petrillo, A, Spolverato, G, Margalef, NM, Diaz, M, Baratelli, C, Puleo, F, Karampeazis, A, Sert, F, Gilliaux, Q, De Stefano, A, Liberale, G, Moretti, L, Martinive, P, Thomas, VD, Staggs, V, Saad, ED, Van Laethem, JL, Sclafani, F. Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncology. 2025; 11(9)DOI:10.1001/jamaoncol.2025.2026. PMID:40638097. IF:20.100(Q1/1D).

Franquesa-Mullerat, M, Morcillo-Nieto, AO, Arriola-Infante, JE, Zsadanyi, SE, Vaqué-Alcázar, L, Rozalem-Aranha, M, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(9)DOI:10.1002/alz.70581. PMID:40968330. IF:11.100(Q1/1D).

Wei, AH, Reyner, JE, Garciaz, S, Aldoss, I, Piérola, A, Allred, A, Dominguez, JMA, Barreyro, L, Bories, P, Daskalakis, N, Porta, MGD, Döhner, H, D'Souza, A, Dugan, J, Fathi, A, Fedele, P, Ferrante, L, Kobos, R, Gaj, S, Diaz, AG, Paniagua, SG, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Trancucci, D, Bamidele, T, Jentzsch, M, Kantarjian, H, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, O'Nions, J, Packman, K, Papayannidis, C, Récher, C, Roellig, C, Salamero, O, Nagarajahastri, P, Sauer, T, Searle, E, Tovar, N, Vallet, N, Vaughan, L, Vega, G, Vyas, P, Platzbecker, U. Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax plus Azacitidine (VEN plus AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/ Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).

Olivella-Cirici, M, Vilagut, G, Sánchez-Ledesma, E, Serral, G, Cortés-Albaladejo, M, Cejas, PM, Pasarín, M, Alonso, J, Pérez, G. Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study. Journal Of Public Health-Heidelberg. 2025; DOI:10.1007/s10389-025-02573-3. PMID:. IF:(Q/D).

Fernandez, RA, Arroyo, A, Cedena, MT, Rosiñol, L, De la Rubia, J, Miqueleiz, S, González-Calle, V, de Arriba, F, Casado-Montero, F, Hernandez, MT, Mas, M, Fernandez-Abellan, P, Rodriguez-Otero, P, Calle, C, Abella, E, Ribas, P, Alegre, A, Bergua, JM, Ocio, E, De la Cruz, J, Mateos, MV, San-Miguel, J, Bladé, J, Lahuerta, JJ, Martinez-Lopez, J. Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).

Gokul-Nath, R, Collins, C, Valverde, L, Lleixa, C, Verdu-Diaz, J, Di Lorenzo, A, Llarch, P, Querol, L, Marini-Bettolo, C, Rojas-Garcia, R, Diaz-Manera, J. Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105462. PMID:. IF:2.800(Q2/5D).

Velasco, JIF, Jorge, FR, Monreal, E, Gracia, J, Díaz, EF, Meca-Lallana, V, Villarrubia, N, de la Maza, SS, Cortegana, EMP, Quiroga-Varela, A, Ramio-Torrentá, L, Martínez-Yélamos, S, Vila, LB, Real, AML, Romero, AR, Canelo, LB, Nicolas, SD, Eguia, P, Espiño, M, Garcia, JLC, Hernandez, FJB, González, JLV, Meca-Lallana, JE, Martos, PG, Gines, MLM, García-Dominguez, JM, Moreno, I, Sainz, R, Mañe, A, Rodriguez, ABC, Pinedo, FC, Labiano, A, Ayuso, L, Abreu, R, Hernández, MA, Rodríguez, MR, Martín-Aguilar, L, González, AH, Rojas, FJV, Cabredo, LF, Sanchez-Seco, VG, Muñoz, JS, Polo, LF, Castañon, IG, Moreno, SMG, Masjuan, J, Costa-Frossard, L, Guimerans, LMV. NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).